A Ukrainian delegation led by Deputy Health Minister Yevhen Honchar held talks in Uzbekistan on Oct. 19-21 aimed at easing regulatory barriers to supplying Ukrainian medicines, the Ukrainian embassy in Tashkent said.
Since Jan. 1, 2026, drugmakers in Uzbekistan must hold a national GMP certificate to register drugs or renew registrations. Ukraine’s Health Ministry said the war and Russian shelling make on-site inspections in Ukraine difficult, putting certificate renewals and shipments at risk.
Ukraine proposed remote or hybrid inspections and temporary extensions of existing certificates during martial law. The ministry said Uzbekistan is preparing legislative changes that would allow remote inspections.
“We are grateful to our Uzbek colleagues for their constructive dialogue and readiness to jointly seek solutions that will ensure uninterrupted exports of Ukrainian medicines,” Honchar said.
On Oct. 21, Uzbekistan’s Pharmaceutical Product Safety Center and Ukraine’s Health Ministry signed a memorandum on regulatory cooperation on medicines and medical devices.
Deputy Minister of Economy and Environment Vitaliy Petruk also met Akram Aliyev, Uzbekistan’s deputy minister of investment, industry and trade, to discuss trade and investment and the possible resumption of regular intergovernmental commission work. The delegation toured Tashkent Pharma Park and the Lekhim plant.
Lekhim opened a representative office in Uzbekistan in 2021 and built a production complex near Tashkent. In February 2024, Ambassador Mykola Doroshenko said equipment installation had been delayed by land cadastral paperwork. The project is valued at $42.5 million.
Stay up to date with all the latest news:
